Interventional device firm ev3 of Plymouth, MN, has received U.S. Food and Drug Administration approval for its Protégé RX carotid stent.
The device, when used in conjunction with the firm's embolic protection device, is indicated for the treatment of carotid artery disease in patients who are at high risk for adverse events from carotid artery surgery, the company said.
By AuntMinnie.com staff writers
January 25, 2007
Related Reading
ev3 stent gets FDA, CE nods for Protégé, March 10, 2006
ev3 stent gets 510(k), October 21, 2004
Copyright © 2007 AuntMinnie.com